Loading…
Azitra, Inc. is projected to rise to $0.1604 by 2027, a +13% move from its current price of $0.142. AZTR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.1322 | $0.1418 | $0.1521 | -0.14% |
| Jul 14 | $0.1282 | $0.1416 | $0.1564 | -0.28% |
| Jul 15 | $0.1252 | $0.1414 | $0.1597 | -0.41% |
| Jul 16 | $0.1227 | $0.1412 | $0.1625 | -0.55% |
| Jul 17 | $0.1205 | $0.141 | $0.165 | -0.69% |
| Jul 18 | $0.1186 | $0.1408 | $0.1673 | -0.82% |
| Jul 19 | $0.1168 | $0.1406 | $0.1694 | -0.96% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1168 | $0.1406 | $0.1694 | -0.96% |
| Week 2 | $0.1071 | $0.1393 | $0.1812 | -1.91% |
| Week 3 | $0.10 | $0.138 | $0.1903 | -2.85% |
| Week 4 | $0.0942 | $0.1366 | $0.1981 | -3.78% |
| Week 5 | $0.0893 | $0.1353 | $0.205 | -4.71% |
| Week 6 | $0.085 | $0.134 | $0.2113 | -5.62% |
| Week 7 | $0.0812 | $0.1327 | $0.217 | -6.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on precision dermatology. It develops therapies using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.
The company is advancing ATR-04, a genetically modified strain of S. epidermidis in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, is in a Phase 1b/2a trial for Netherton syndrome; and ATR-01, a genetically modified strain of S.
epidermidis that expresses an engineered recombinant human filaggrin protein, is in the IND-enabling phase for treating ichthyosis vulgaris. It also has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations.
Azitra was incorporated in 2014 and is headquartered in Branford, Connecticut.
Azitra, Inc. (AZTR) currently trades with a price of $0.1511 and carries a market capitalization of $2.45M, ranking 5302 among listed securities.
Technical picture shows a BEARISH stance with RSI(14) at 40. The stock trades below the SMA50 of $0.2109 and below the SMA200 of $0.3261. Support is at $0.151 and resistance at $0.238.
The 30-day price range spans from $0.0884 to $0.2582, and annualized volatility stands at 200%. The near-term technical backdrop complements the bearish tone seen in momentum indicators, while the forecast suggests potential upside opportunities over the longer horizon.
A major floor 45.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 67.6% above — a clean break opens room to run.
A major ceiling 109.2% above — clearing it would confirm fresh momentum.
Key AZTR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AZTR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.1484 | Sell | $0.1494 | Sell |
| MA 10 | $0.1572 | Sell | $0.1585 | Sell |
| MA 20 | $0.1789 | Sell | $0.1732 | Sell |
| MA 50 | $0.2033 | Sell | $0.1947 | Sell |
| MA 100 | $0.2053 | Sell | $0.2413 | Sell |
| MA 200 | $0.3104 | Sell | $1.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.09 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -103.89 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -32.38 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.98 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 20.96 | Buy |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.14 | Sell |
| ADX (14) | 16.61 | Neutral |
| ATR (14) | 0.01 | Info |
The near-term picture centers on the 30-day window: $0.0884 to $0.2582.
RSI(14) is 40, indicating modest bearish momentum. The stock is trading below the SMA50 ($0.2109) and below the SMA200 ($0.3261), which reinforces the current softer tone.
Key near-term levels to watch are support at $0.151 and resistance at $0.238.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.137 | $0.142 | $0.1486 | 0% | Neutral | |
| $0.1164 | $0.1604 | $0.239 | +13% | Neutral | |
| $0.1296 | $0.1898 | $0.3015 | +34% | Bullish | |
| $0.1202 | $0.1854 | $0.3091 | +31% | Bullish | |
| $0.1066 | $0.1725 | $0.2993 | +21% | Bullish | |
| $0.0927 | $0.1567 | $0.2816 | +10% | Neutral | |
| $0.0891 | $0.1572 | $0.2912 | +11% | Neutral | |
| $0.0883 | $0.1622 | $0.3088 | +14% | Neutral | |
| $0.113 | $0.2158 | $0.4212 | +52% | Bullish | |
| $0.1231 | $0.2445 | $0.4883 | +72% | Bullish | |
| $0.1349 | $0.2998 | $0.6581 | +111% | Bullish | |
| $0.1624 | $0.361 | $0.8302 | +154% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.137 | $0.142 | $0.1767 | +0.00% |
| August 2026 | $0.11 | $0.1333 | $0.1681 | -6.14% |
| September 2026 | $0.1019 | $0.1252 | $0.1613 | -6.04% |
| October 2026 | $0.1034 | $0.1286 | $0.1686 | +2.71% |
| November 2026 | $0.0979 | $0.123 | $0.1635 | -4.37% |
| December 2026 | $0.087 | $0.1103 | $0.1486 | -10.31% |
Click any year to see its month-by-month AZTR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Azitra, Inc.'s 2026 outlook centres on $0.142, within a $0.137 to $0.1486 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AZTR could reach as high as $0.239, with a base case around $0.1604 and support toward $0.1164 — roughly +13% from $0.142. A consolidation phase looks the most probable path here.
Expect AZTR to range from $0.1296 to $0.3015 through 2028. The $0.1898 average target implies a +34% move from current prices. That is up +18% on the projected 2027 average. Momentum favours further upside here.
The AZTR price prediction for 2029 points to an average of $0.1854 (low $0.1202, high $0.3091) — a potential gain of +31% on today's $0.142. Buyers look set to stay in control over this stretch.
In 2030, AZTR is projected to trade between $0.1066 and $0.2993, averaging $0.1725 — a potential gain of +21% from today's $0.142. That is -7% versus the projected 2029 average. Momentum favours further upside here.
Azitra, Inc.'s 2031 outlook centres on $0.1567, within a $0.0927 to $0.2816 range. That is -9% versus the projected 2030 average. That marks a +10% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AZTR could reach as high as $0.2912, with a base case around $0.1572 and support toward $0.0891 — roughly +11% from $0.142. Price action looks broadly range-bound.
Expect AZTR to range from $0.0883 to $0.3088 through 2033. The $0.1622 average target implies a +14% move from current prices. That is up +3% on the projected 2032 average. A consolidation phase looks the most probable path here.
The AZTR price prediction for 2034 points to an average of $0.2158 (low $0.113, high $0.4212) — a potential gain of +52% on today's $0.142. Momentum favours further upside here.
In 2035, AZTR is projected to trade between $0.1231 and $0.4883, averaging $0.2445 — a potential gain of +72% from today's $0.142. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Azitra, Inc.'s 2040 outlook centres on $0.2998, within a $0.1349 to $0.6581 range. That is up +23% on the projected 2035 average. That marks a +111% change versus current levels. Momentum favours further upside here.
By 2050, AZTR could reach as high as $0.8302, with a base case around $0.361 and support toward $0.1624 — roughly +154% from $0.142. Buyers look set to stay in control over this stretch.
Investing $1,000 in AZTR today (≈ 7,042.253521 AZTR) could be worth
$2,541.95
+$1,541.95 (+154%) by 2050 · US Dollar
Based on the average projected AZTR price of $0.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AZTRwould be worth at today's price.
$1,000 invested in AZTR on Jul 10, 2025 (≈ 592.88527 AZTR) would be worth
$84.19
-$915.81 (-91.6%) today · 0.08× · US Dollar
Based on a AZTR entry price of $1.69 vs. today's $0.142.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.151 | $940.4 | -6.0% |
| 1 month ago | $0.238 | $596.64 | -40.3% |
| 3 months ago | $0.227 | $625.55 | -37.4% |
| 6 months ago | $0.305 | $465.57 | -53.4% |
| 1 year ago | $1.69 | $84.19 | -91.6% |
| All time (3.1y) ago | $988 | $0.14 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AZTR forecast.
Our base-case forecast reaches $0.28 around 2040.
Implied market cap at $0.28: $4.53M
Over the multi-year forecast horizon, the outlook shifts from neutral to bullish in later years. The 2026 average is $0.1511 with a 0% ROI, and sentiment is Neutral.
In 2030, the average is $0.1878 with a 24.3% ROI and a bullish sentiment, signaling measurable upside as the period advances.
The upside accelerates into the mid-2020s and beyond, with 2034 averaging $0.2265 and a 49.9% ROI (bullish), and 2035 averaging $0.2616 with a 73.1% ROI (bullish).
Longer term, 2040 shows an average of $0.3147 with an 108.3% ROI, and 2050 projects an average of $0.3835 with a 153.8% ROI, both marked as bullish. These are estimates and not guarantees, reflecting potential upside under the provided scenarios but carrying uncertainty and risk inherent in early-stage equities.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $0.1878 with a 24.3% ROI and a bullish sentiment.
The forecast shows gradual upside with, for example, 2027 avg $0.1767 (ROI 16.9%), 2028 avg $0.1996 (ROI 32.1%), and 2030 avg $0.1878 (ROI 24.3%), but near-term sentiment is Neutral overall and the current technical picture is bearish.
Yes. The forecast maximums include $0.5227 in 2035, $0.6912 in 2040, and $0.8819 in 2050, all above $0.50.
The long-term view shows bullish sentiment with 2034 avg $0.2265 (ROI 49.9%), 2035 avg $0.2616 (ROI 73.1%), 2040 avg $0.3147 (ROI 108.3%), and 2050 avg $0.3835 (ROI 153.8%).
The 30-day range is $0.0884 to $0.2582.
Azitra, Inc. Community Discussion
0Share your Azitra, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.